Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial
dc.contributor.author | Popat, R. | |
dc.contributor.author | Counsell, N. | |
dc.contributor.author | de Tute, R. | |
dc.contributor.author | De-Silva, D. | |
dc.contributor.author | Phillips, Elizabeth H | |
dc.contributor.author | Cavenagh, J. D. | |
dc.contributor.author | Adedayo, T. | |
dc.contributor.author | Braganca, N. | |
dc.contributor.author | Roddie, C. | |
dc.contributor.author | Streetly, M. | |
dc.contributor.author | Schey, S. | |
dc.contributor.author | Koh, M. B. C. | |
dc.contributor.author | Crowe, J. | |
dc.contributor.author | Morris, T. C. | |
dc.contributor.author | Cook, G. | |
dc.contributor.author | Smith, P. | |
dc.contributor.author | Clifton-Hadley, L. | |
dc.contributor.author | Rabin, N. | |
dc.contributor.author | Owen, R. | |
dc.contributor.author | Yong, K. | |
dc.date.accessioned | 2021-04-20T08:08:23Z | |
dc.date.available | 2021-04-20T08:08:23Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Popat R, Counsell N, de Tute R, De-Silva D, Phillips EH, Cavenagh JD, et al. Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. Br J Haematol. 2021. | en |
dc.identifier.pmid | 33715154 | en |
dc.identifier.doi | 10.1111/bjh.17391 | en |
dc.identifier.uri | http://hdl.handle.net/10541/623951 | |
dc.description.abstract | None | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1111/bjh.17391 | en |
dc.title | Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial | en |
dc.type | Other# | en |
dc.contributor.department | UCL Cancer Institute, London, UK | en |
dc.identifier.journal | British Journal of Haematology | en |
dc.description.note | en] | |
refterms.dateFOA | 2021-04-26T08:17:30Z |